Simmons Jeffrey N's Form 4 filing
Elanco Animal Health Inc (ELAN) · filed Mar 13, 2023
- Accession no.
- 0001415889-23-004744
- Filed
- Mar 13, 2023
- Trade date
- Mar 10, 2023
- Filing delay
- 3 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 1 non-derivative transaction. Open-market purchases total $144.0K. It was filed 3 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Simmons Jeffrey NCIK 0001479079 | Director, Officer (PRESIDENT, CEO AND DIRECTOR) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 10, 2023 | Common Stock | PPurchaseAcquired | +15,000 | $9.60F1 | +$144,000 | 45,000 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
Reflects the weighted average price of 15,000 shares of common stock of Elanco Anima Health Inc. purchased by the reporting person in multiple transactions on March 10, 2023 with purchase prices ranging from $9.585 to $9.5999 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.
Referenced by the price of 1 transaction in Table I.